Sam Brusco, Associate Editor02.05.21
SteriPack, a contract manufacturer of medical, consumer healthcare, diagnostic, pharmaceutical, and combination devices, has named Andrew McLean as the company's president and CEO. He will succeed Garry Moore who will continue as Chairman.
"When I founded SteriPack I was determined the culture of our company would be underpinned by an intense focus on the customer, solving their problems and helping them achieve their goals, and I know Andrew will reinforce and build upon this," Moore told the press.
Andrew McLean brings over 20 years of medical device and pharmaceutical expertise to SteriPack, with prior leadership roles at Pfizer, BD, Synergy Health, Steris Corp. and more recently, CEO at Sirtex Medical.
"SteriPack is a highly responsive contract manufacturer providing integrated product lifecycle management solutions,” commented McLean. “This company truly is a team of wonderful, talented individuals, and I am thrilled to be joining SteriPack.”
"When I founded SteriPack I was determined the culture of our company would be underpinned by an intense focus on the customer, solving their problems and helping them achieve their goals, and I know Andrew will reinforce and build upon this," Moore told the press.
Andrew McLean brings over 20 years of medical device and pharmaceutical expertise to SteriPack, with prior leadership roles at Pfizer, BD, Synergy Health, Steris Corp. and more recently, CEO at Sirtex Medical.
"SteriPack is a highly responsive contract manufacturer providing integrated product lifecycle management solutions,” commented McLean. “This company truly is a team of wonderful, talented individuals, and I am thrilled to be joining SteriPack.”